Cranial involvement in giant cell arteritis

Philipp Bosch1, Georgina Espigol-Frigolé2, Maria C Cid2

  • 1Department of Rheumatology and Immunology, Medical University of Graz, Graz, Austria.

PubMed

Insights

Giant cell arteritis research has improved diagnosis and management. Current studies focus on large vessel involvement, new therapies to reduce steroid use, and updated clinical guidelines.

Area of Science:

  • Rheumatology
  • Vascular Medicine
  • Internal Medicine

Background:

  • Giant cell arteritis (GCA) is a vasculitis affecting large arteries, primarily the aorta and its branches.
  • Historically diagnosed based on cranial artery involvement, GCA is now recognized to frequently impact extracranial large vessels.
  • Advances in understanding GCA pathophysiology have spurred the development of novel therapeutic strategies.

Purpose of the Study:

  • To review the current understanding of giant cell arteritis, focusing on cranial manifestations.
  • To outline the contemporary clinical approach to diagnosing and managing GCA.
  • To explore emerging research and future directions in GCA patient care.

Main Methods:

  • Literature review of recent advancements in GCA research.
  • Analysis of updated classification criteria and management recommendations.
  • Synthesis of basic, translational, and clinical research findings.

Main Results:

  • Significant progress in GCA diagnosis and patient management since 1890.
  • Recognition of widespread large vessel involvement in GCA beyond cranial arteries.
  • Development of new therapeutic agents aiming to minimize glucocorticoid dependence and prevent disease flares.

Conclusions:

  • GCA is a complex vasculitis with significant large vessel implications.
  • Updated guidelines and novel therapies are transforming GCA management.
  • Ongoing research promises further improvements in GCA treatment and patient outcomes.